Terms ending in 2027
Every in-force patent on Vertical Pharmaceuticals, LLC's record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,252,328 | Bioadhesive Drug Formulations for Oral Transmucosal Delivery In force · Medium confidence | Vertical Pharmaceuticals, LLC | In force | Medium confidence | |
| US 8,535,714 | Small Volume Oral Transmucosal Dosage Forms Containing Sufentanil for Treatment of Pain In force · Medium confidence | Vertical Pharmaceuticals, LLC | In force | Medium confidence | |
| US 9,320,710 | Small Volume Oral Transmucosal Dosage Forms Containing Sufentanil for Treatment of Pain In force · High confidence | Vertical Pharmaceuticals, LLC | In force | High confidence | |
| US 9,744,129 | Small Volume Oral Transmucosal Dosage Forms Containing Sufentanil for Treatment of Pain In force · High confidence | Vertical Pharmaceuticals, LLC | In force | High confidence | |
| US 10,245,228 | Small Volume Oral Transmucosal Dosage Forms Containing Sufentanil for Treatment of Pain In force · High confidence | Vertical Pharmaceuticals, LLC | In force | High confidence | |
| US 10,342,762 | Small-Volume Oral Transmucosal Dosage Forms In force · Medium confidence | Vertical Pharmaceuticals, LLC | In force | Medium confidence | |
| US 10,507,180 | Small Volume Oral Transmucosal Dosage Forms Containing Sufentanil for Treatment of Pain In force · High confidence | Vertical Pharmaceuticals, LLC | In force | High confidence | |
| US 8,226,978 | Small Volume Oral Transmucosal Dosage Forms Containing Sufentanil for Treatment of Pain In force · Medium confidence | Vertical Pharmaceuticals, LLC | In force | Medium confidence | |
| US 7,901,710 | Nutritional Supplement for Use Under Physiologically Stressful Conditions In force · High confidence | Vertical Pharmaceuticals, LLC | In force | High confidence | |
| US 8,252,329 | Bioadhesive Drug Formulations for Oral Transmucosal Delivery In force · Medium confidence | Vertical Pharmaceuticals, LLC | In force | Medium confidence | |
| 1 more term end in 2027 · Pro | |||||
10 of 11 patents shown. Soonest term end first, then patent number.
Pro members see all 11, all of them expiring within the 18 months from Nov 19, 2026.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.